journal
Journals International Journal of Gynec...

International Journal of Gynecological Pathology

https://read.qxmd.com/read/38661558/high-grade-serous-carcinoma-occurring-in-a-serous-cystadenoma-on-the-background-of-a-serous-tubal-intraepithelial-carcinoma-stic-like-lesion-a-case-report-with-literature-review
#1
JOURNAL ARTICLE
Filipp Vladimirovich Novikov, Aleksandr Grigorevich Anufriev, Gennadii Dmitrievich Efremov
At present, the prevailing concept is that high-grade serous carcinoma (HGSC) arises from the fallopian tubes (FTs). We report an HGSC case occurring in a serous ovarian cyst against the background of a serous tubal intraepithelial carcinoma (STIC)-like lesion. We also provide a literature review that contains references to clinical cases of the occurrence of STIC-like lesions in the ovary and phylogenetic studies that do not always reveal obvious bonds between early dysplastic serous lesions and HGSC. The article discusses cases of association between HGSCs of serous borderline tumors (SBTs) and low-grade serous carcinomas (LGSCs) in the context of their possible histogenetic relationship...
April 18, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38661560/human-papillomavirus-associated-multiphenotypic-carcinoma-first-description-of-a-vulval-case
#2
JOURNAL ARTICLE
Charlotte C Currie, Darren Leaning, W Glenn McCluggage, Emma Spoor
Human papillomavirus (HPV)-associated multiphenotypic sinonasal carcinoma is a rare and recently described epithelial neoplasm exhibiting myoepithelial differentiation and morphological overlap with salivary gland neoplasms, especially adenoid cystic carcinoma; it is commonly associated with HPV, especially type 33. It has mainly been reported in the nasal cavity and paranasal sinuses with a single case reported in the breast. Herein, we report the first vulval example in a 47-year-old patient who presented with a large craggy mass in the region of the Bartholin gland...
April 9, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38661555/erythrasma-of-the-vulva-an-invisible-dermatosis
#3
JOURNAL ARTICLE
Soma Jobbagy, Alvaro C Laga, Jaclyn C Watkins
Erythrasma is a prevalent superficial bacterial infection typically caused by Corynebacteria species and preferentially affecting intertriginous sites including axillary, interdigital, and inguinal skin folds. However, erythrasma of the vulva is uncommon, with only 2 cases previously reported. Although erythrasma can be diagnosed clinically using Woods lamp examination, it may not always be considered in the differential diagnosis for patients presenting with persistent vulvar pruritus. We report 12 cases of vulvar erythrasma identified by histopathology, with a review of clinical and histologic features...
April 9, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38661526/clinicopathologic-characteristics-of-a-single-institution-cohort-of-ovarian-adult-granulosa-cell-tumors-with-biomarker-and-therapeutic-implications-utilizing-the-detection-of-androgen-estrogen-and-progesterone-hormone-receptor-expression-by-immunohistochemistry
#4
JOURNAL ARTICLE
Michelle Moh, Andrii Puzyrenko, Rebekah Summey, Janet S Rader, Genaro Enrique Herrera Cano, Jennifer V Gavina, Hallgeir Rui, Yunguang Sun, Elizabeth Hopp
Adult granulosa cell tumors (AGCTs) are rare ovarian tumors with generally good prognosis after surgical resection; however, they do have recurrence potential. Therapeutic and management options for recurrences are currently limited, and the need for expanded adjuvant therapies is increasingly recognized. Anti-hormonal therapy is being explored as an option, which relies on the detection and assessment of hormone receptor expression (androgen, estrogen, and progesterone receptors) as a biomarker and therapeutic target...
March 27, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38661557/endometrial-cancer-in-a-family-with-rad51d-gene-mutation
#5
JOURNAL ARTICLE
Brittany Gilmore, Linda Logan, Wendy McKinnon, Elise Everett, Bronwyn H Bryant
RAD51 complex plays an important role in homologous recombination deficiency and germline mutations have a well-documented association with breast and tubo-ovarian carcinoma, as well as serous-type endometrial carcinoma. We report a family of French Canadian ancestry with a germline mutation in RAD51D and two sisters presenting with endometrial carcinoma, endometrioid-type. The risk factors for endometrial adenocarcinoma, endometrioid-type are discussed in the context of the RAD51-associated carcinomas described to date...
March 25, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38501593/a-novel-epc1-kdm2b-fusion-in-high-grade-endometrial-stromal-sarcoma
#6
JOURNAL ARTICLE
Katherine M Vroobel, Sana Khalid, Silvia Cavalchini, Ayoma D Attygalle
The spectrum of endometrial stromal sarcoma (ESS) has expanded substantially since the publication of the most recent World Health Organisation (WHO) Classification of Female Genital Tumours and the advent of widely available genomic testing. We describe a uterine mesenchymal tumor harboring a novel EPC1::KDM2B fusion, best classified within the umbrella of high-grade endometrial stromal sarcoma (HGESS). This tumor was composed of a uniform population of spindled cells with some myxoid stroma, a mitotic rate of up to 21/10 high-power fields, and a largely pushing margin with focal vascular invasion...
March 11, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38436360/her2-low-and-overexpression-in-mucinous-ovarian-cancer-analysis-of-asco-cap-and-toga-immunohistochemical-scoring
#7
JOURNAL ARTICLE
Rachel Han, Ainhoa Madariaga, Eduardo Gonzalez-Ochoa, Adam C Smith, Lisa Wang, Stephanie Lheureux, Marjan Rouzbahman
Mucinous ovarian carcinoma is an uncommon malignancy characterized by resistance to chemotherapy and poor survival in the metastatic setting. HER2 amplification is a frequent late event in carcinogenesis, yet the incidence of HER2-low in mucinous ovarian carcinoma is unknown. Further, the optimal method for determining overexpression in these tumors is not established. We sought to assess the ASCO/CAP and ToGA trial scoring methods for HER2 IHC with correlation to FISH, p53, and mismatch repair protein status and to determine the incidence of HER2-low in mucinous ovarian carcinoma...
March 4, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38436404/gynecologic-pathology-journal-club-a-2-year-worldwide-virtual-learning-experience-with-a-focus-on-mentorship-and-inclusion
#8
JOURNAL ARTICLE
Natalie Banet, Carlos Parra-Herran, Joseph T Rabban, Esther Oliva, Lora H Ellenson, Kay J Park, Naveena Singh, Kyle M Devins, Sameera Rashid, Karen L Talia
Journal clubs (JCs) are a common format used in teaching institutions to promote trainee engagement and develop skills in seeking out evidence-based medicine and critically evaluating literature. Digital technology has made JC accessible to worldwide audiences, which allows for increased inclusion of globally diverse presenters and attendees. Herein we describe the experience of the first 2 years of a virtual gynecologic pathology JC designed with the goal of providing mentorship and increasing inclusivity...
February 19, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38426544/novel-foxl2-mutation-in-an-ovarian-adult-granulosa-cell-tumor-report-of-a-case-with-diagnostic-and-clinicopathologic-implications
#9
JOURNAL ARTICLE
Agnes Nagy, Na Niu, Elena Ratner, Pei Hui, Natalia Buza
Adult granulosa cell tumor, the most common malignant ovarian sex cord-stromal tumor, harbors the characteristic mutation c.402C>G (p.C134W) in the FOXL2 gene in ~90% to 95% of cases. To date, no other variants of FOXL2 mutations have been identified in these tumors. Here we report the first case of an adult granulosa cell tumor with a novel FOXL2 point mutation c.398C>T (p.A133V) presenting in a 64-year-old postmenopausal woman. The patient underwent total hysterectomy and bilateral salpingo-oophorectomy for atypical endometrial hyperplasia and gross examination revealed an incidental 3...
February 19, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38329416/well-differentiated-squamous-cell-carcinoma-with-sarcomatous-differentiation-in-patient-with-a-history-of-recurrent-verrucous-carcinoma
#10
REVIEW
Komal Ijaz, Eric Johannesen, Van Nguyen T
Human papillomavirus-independent vulvar squamous cell carcinoma has a peak incidence in about the eighth decade of life. A variable portion of the vulvar squamous cell carcinoma are human papillomavirus-independent comprising 20% to 80% of all cases. Verrucous carcinoma (VC) is part of the spectrum of human papillomavirus-independent carcinomas and its combination with well-differentiated squamous cell carcinoma with sarcomatous differentiation is an extremely unusual neoplasm. The available literature on VC is currently limited to case reports and small single-institution studies...
March 1, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38329415/lawrence-m-roth-md-1936-2023
#11
JOURNAL ARTICLE
Thomas M Ulbright
No abstract text is available yet for this article.
March 1, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/37922952/ovarian-endometrioid-adenocarcinomas-with-infiltrative-adenofibroma-like-morphology-and-aberrant-%C3%A3-catenin-expression-tumors-that-coexpress-cdx2-and-lef1-with-frequent-neuroendocrine-marker-expression-diminished-lost-pax8-and-possible-association-with-endometrioid
#12
JOURNAL ARTICLE
https://read.qxmd.com/read/38303111/pd-l1-expression-in-hpv-associated-versus-hpv-independent-invasive-vulvar-squamous-cell-carcinoma
#13
JOURNAL ARTICLE
Chau Minh Bui, Fabiola Medeiros, Mahzad Azimpouran, Mariza Venturina, Bonnie Balzer
Two etiological pathways have been implicated in the pathogenesis of vulvar squamous cell carcinoma (VSCC): a high-risk human papillomavirus (HPV)-associated route and an HPV-independent pathway characterized by TP53 mutations. Programmed cell death ligand 1 (PD-L1) has become increasingly useful in predicting the response to checkpoint inhibitor therapy in squamous cell carcinomas at various anatomical sites. This study aimed to assess the association between PD-L1 expression and the VSCC subtype to evaluate the utility of PD-L1 in prognostication and therapeutic selection based on HPV status...
February 2, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38303108/does-one-size-fits-all-rethinking-figo-depth-of-invasion-measurements-in-vulvar-cancer
#14
JOURNAL ARTICLE
Maaike C G Bleeker, Tjalling Bosse, Koen K van de Vijver, Joost Bart, Hugo Horlings, Trudy G N Jonges, Nicole C M Visser, Loes F S Kooreman, Johan Bulten, Patricia C Ewing-Graham
Depth of invasion (DOI) is an important diagnostic parameter in patients with vulvar carcinoma, where a cutoff value of 1 mm largely determines the tumor stage and the need for groin surgery. DOI measurement should be reproducible and straightforward. In light of the new recommendation on how to measure DOI in the International Federation of Gynecology and Obstetrics (FIGO) staging system 2021, an exploratory study was conducted on the current practice of DOI measurement in vulvar cancer. In this study of 26 selected cases, 10 pathologists with high exposure to vulvar cancer cases in daily practice assessed both the conventional (FIGO 2009) and alternative (FIGO 2021) DOI methods for applicability and preference...
February 2, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38303106/endometrial-carcinosarcomas-are-almost-exclusively-of-p53abn-molecular-subtype-after-exclusion-of-mimics
#15
JOURNAL ARTICLE
Jutta Huvila, Amy Jamieson, Jennifer Pors, Lynn Hoang, Jelena Mirkovic, Dawn Cochrane, Jessica N McAlpine, C Blake Gilks
INTRODUCTION: Our aim was to assess the molecular subtype(s) and perform a detailed morphologic review of tumors diagnosed as carcinosarcoma in a population-based cohort. METHODS: Forty-one carcinosarcomas were identified from a cohort of 973 endometrial carcinomas diagnosed in 2016. We assessed immunostaining and sequencing data and undertook expert pathology reviews of these cases as well as all subsequently diagnosed (post-2016) carcinosarcomas of no specific molecular profile (NSMP) molecular subtype (n=3) from our institutions...
February 2, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38294060/high-risk-human-papillomavirus-associated-mixed-intestinal-type-mucinous-adenocarcinoma-and-low-grade-neuroendocrine-tumor-of-the-uterine-cervix-report-of-a-case-harboring-shared-arid1a-and-smad4-mutations-between-morphologically-distinct-components
#16
JOURNAL ARTICLE
Rofieda Alwaqfi, Kaitlyn Gill, David N Brown, Britta Weigelt, Kay J Park, M Herman Chui
No abstract text is available yet for this article.
January 31, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38294049/risk-factors-affecting-clinical-outcomes-of-low-risk-early-stage-human-papillomavirus-associated-endocervical-adenocarcinoma-treated-by-surgery-alone-application-of-silva-pattern
#17
JOURNAL ARTICLE
Bong Kyung Bae, Hyunsik Bae, Won Kyung Cho, Byoung-Gie Kim, Chel Hun Choi, Tae-Joong Kim, Yoo-Young Lee, Jeong-Won Lee, Hyun-Soo Kim, Won Park
This study aimed to report the clinical outcomes and risk factors for survival of patients with low-risk early-stage human papillomavirus-associated (HPVA) endocervical adenocarcinoma (EAC) treated with surgery alone. This retrospective study obtained the clinicopathological data of patients with early-stage HPVA EAC who underwent surgery between 2012 and 2018. The Silva pattern of invasion was determined by reviewing pathology slides. Locoregional recurrence-free survival (RFS), RFS, and overall survival were calculated, and the risk factors for survival were analyzed...
January 31, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38293999/pd-l1-expression-and-silva-invasion-pattern-in-villoglandular-adenocarcinoma-of-the-uterine-cervix
#18
JOURNAL ARTICLE
Anna K Dietl, Matthias W Beckmann, Frederik A Stuebs, Paul Gass, Julius Emons, Arndt Hartmann, Ramona Erber
Villoglandular adenocarcinoma (VGA) of the uterine cervix is a rare subtype of endocervical adenocarcinoma in young women. Between 2007 and 2020, all women with endocervical adenocarcinoma were retrospectively reviewed to find patients with VGA. Eight patients in whom pure VGA had been diagnosed were included. The mean age at initial diagnosis was 36.3 years (range 24-46). After surgical treatment, patients were followed up for 59 months (range 16-150). To date, all patients are alive with no evidence of disease...
January 31, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38293998/predicting-progestin-therapy-response-with-pten-pax2-and-%C3%AE-catenin-in-patients-with-endometrioid-precancer
#19
JOURNAL ARTICLE
Naijia Liu, Wanrun Lin, Yan Wang, Zhigang Yao, Glorimar Rivera-Colon, Yan Li, Kelley S Carrick, Hao Chen, Elena Lucas, Wenxin Zheng
This study investigates the predictive value of biomarkers PTEN, PAX2, and β-catenin for therapeutic outcomes in patients with atypical endometrial hyperplasia or endometrioid intraepithelial neoplasia undergoing progestin therapy. In a retrospective study of 128 patients, we analyzed a total of 351 endometrial biopsy samples and categorized outcomes into responders (absence of residual disease) and nonresponders (presence of residual disease). We found aberrant biomarker expression in pretreatment cases: 48% for PTEN, 65% for PAX2, and 36% for β-catenin...
January 31, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38291567/evaluation-of-combined-p57kip2-immunohistochemistry-and-fluorescent-in-situ-hybridization-analysis-for-hydatidiform-moles-compared-with-genotyping-diagnosis
#20
JOURNAL ARTICLE
Hirokazu Usui, Kazufusa Hoshimoto, Asuka Sato, Motofumi Kano, Toshio Fukusato, Yukio Nakatani, Makio Shozu
Immunostaining with p57KIP2 is a widely used diagnostic technique to differentiate complete hydatidiform moles (CHMs) from partial hydatidiform moles (PHM) and non-molar hydropic abortion. However, distinguishing between PHMs and non-molar hydropic abortions using histopathology alone is often challenging. This study aimed to evaluate the technical validity and additional benefits of using fluorescence in situ hybridization (FISH) in combination with p57KIP2 immunostaining to diagnose molar and non-molar conceptuses...
January 31, 2024: International Journal of Gynecological Pathology
journal
journal
28436
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.